SINCE 2014, SEN-JAM HAS BEEN ON A MISSION
TO REVOLUTIONIze INFLAMMATORY CARE

Sen-Jam is Redefining Inflammatory Care for the Next Era of Medicine

We believe the future of healthcare starts upstream—by addressing inflammation at its root, not reacting to its consequences.

Since our founding in 2014, we’ve pursued one mission: to advance safe, effective solutions that help preserve health before disease takes hold. Our work targets a $10T global burden—where chronic inflammation drives the majority of modern illness, disability, and economic cost.

Our proprietary platform pairs proven molecules in novel ways to reshape inflammatory care—spanning applications from pain management to systemic inflammation, from consumer wellness to critical care. We focus relentlessly on non-opioid, non-suppressive therapeutics designed to work with the body’s natural systems—not against them.

Sen-Jam collaborates with visionary partners across science, distribution, and licensing. Together, we are building a future where healthcare moves upstream—preserving vitality, productivity, and quality of life at scale

Group 15383

Sen-Jam has been working hard building strategic partnerships, driving momentum and amassing 60+ both domestic and international patents and patents pending

2014

The Eureka Moment

A Pharmacist’s Intuition Sparks a Revolution

It all began with a question: Why are we treating pain when inflammation is the real culprit? While the world numbed symptoms, visionary pharmacist Jackie Iversen, RPh MS, saw the flaw in the system. Her ‘aha!’ moment wasn’t just insight — it was ignition. In 2014, the seed of what would become Sen-Jam was planted: a radical new approach to intercept inflammation at its root and unlock a healthier, more resilient human experience.

Our Leadership Team

Masters of the science. Stewards of the mission. Innovating with the spirit of Good Karma Pharma.

We believe scientific excellence and commercial impact can—and must—coexist with integrity, empathy, and vision. That’s the ethos driving everything we do.

Jacqueline Iversen, RPh, MS

Co-Founder, Chief Clinical Officer

Jackie has extensive knowledge and capabilities in a multitude of clinical settings. Her expertise involves providing clinical education across the healthcare continuum. In particular, upon completing a rigorous research fellowship in pharmacokinetics and pain at Memorial Sloan Kettering Cancer Center, Jackie saw new possibilities other colleagues and thought leaders missed.  She is a passionate innovator and humanitarian with her eye always firmly on the ultimate impact to people in all places and stages of health and life.

Group 15485
Ellipse 721

Jim Iversen
Co-Founder/CEO

Jim is a Seasoned Executive and Charismatic Leader with a consistent track record of developing and executing business strategies that deliver rapid growth in sales, profits, market share, employee and customer satisfaction. He thrives in fast paced environments, producing results through remarkable resourcefulness and collaborations.  A Strategic Powerhouse, Jim has a knack for seeing the big picture and stewarding multiple pathways to success. Client engagements range from start-ups to late stage, often resulting in an M&A transaction.

Ellipse 722

Thomas Dahl, PhD
Head of Product Development and Regulatory Affairs

Tom has held several senior management positions with companies ranging from start-ups to established global companies. He is an accomplished biotech/pharmaceutical executive with expertise in early stage ventures, including technical analysis of products and technologies, business strategy and operations, development program strategy, clinical trial design and interpretation, and interfacing with pharmaceutical partners.

Ellipse 723

Christine Leonard
Head of Strategic Communications

Christine is a highly respected and award-winning marcom strategist with passion for companies that aim to improve lives. She has led brand development, marketing execution, investor relations, consumer insight mining and communications excellence for world-class healthcare companies big and small. Christine has a unrelenting passion for collaborating with entrepreneurs who disrupt markets for massively good outcomes to humanity. She believes the world needs radically fresh solutions to age-old problems.

Ellipse 720

Neal Zahn
Head of Global Licensing

Wildly successful and seasoned executive in the manufacturing, operations and pharmaceutical industries, Neal is a powerhouse in global connection.  With a strong bench of skills in the business development space, he has fine tuned his legendary resourcefulness in building long lasting, high impact strategic alliances. Neal is charming and unflappable, bringing optimism and pragmatism to the global stage.

"Arguably the world's most resourceful healthcare company.
Revolutionizing inflammation with a rocket ship of opportunity"

Alexander Wissner-Gross

Group 15391 (1)

Scientific Advisory Board

A Small, Mighty Force—Seasoned Builders. Visionary Futurists. Relentless Scientists.

We are a hand-picked team of world-class pharmacists, proven dealmakers, pioneering technologists, and leading immunologists—advancing a platform designed to shift inflammatory care upstream.

In a $10T+ inflammation-driven world, precision beats scale—and vision defines the winners. We’re here to redefine what’s possible.

Join Our Mailing List

Forge a Partnership

Media Inquiry